NCT07255443

Brief Summary

significant benefits by providing data to improve infection control, guide early detection, and reduce CRE transmission in ICUs.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
12mo left

Started Feb 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress28%
Feb 2026Jun 2027

First Submitted

Initial submission to the registry

November 20, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 1, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

February 1, 2026

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2027

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 5, 2027

Last Updated

December 1, 2025

Status Verified

November 1, 2025

Enrollment Period

1 year

First QC Date

November 20, 2025

Last Update Submit

November 20, 2025

Conditions

Rate of Carbapenemase Intestinal Carrier Inside ICU

Outcome Measures

Primary Outcomes (1)

  • rate of intestinal colonization with CRE

    One year

Study Arms (1)

Prospective cohort study conducted in the Adult ICU at Assiut University Hospital

Other: Observational study

Interventions

Observational studyOTHER

Observational study

Prospective cohort study conducted in the Adult ICU at Assiut University Hospital

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All eligible adult patients admitted during the study period

You may qualify if:

  • Adults (≥18 years)\_
  • Expected ICU stay ≥48 hours -

You may not qualify if:

  • ICU stay \<48 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Observation

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Resistant doctor

Study Record Dates

First Submitted

November 20, 2025

First Posted

December 1, 2025

Study Start

February 1, 2026

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

June 5, 2027

Last Updated

December 1, 2025

Record last verified: 2025-11